SunGen Pharmaceuticals

CCIT Lab 124 675 US Highway
One North Brunswick
New Jersey
08902
United States

Tel: 888-783-1118

About SunGen Pharmaceuticals

SunGen Pharma LLC DBA Peterson Pharmaceuticals is a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products. SunGen specializes in the development of oral solid extended release, complex injectable products, patch, cream and ointment, and other high entry barrier products. SunGen has business partnerships with many US based and global pharmaceutical companies to develop, manufacture, and sell pharmaceutical products around the world.
LEADERSHIP:
CEO: Isaac Liu

10 articles about SunGen Pharmaceuticals

SunGen and Camber Announce U.S. Launch of Generic Version of Bentyl® (Dicyclomine) Injection

1/24/2020

SunGen Pharma announced the U.S. launch and commercial shipment of generic version of Bentyl® Injection, in collaboration with Camber Pharmaceuticals, who will be SunGen's distribution and marketing partner.
SunGen Pharma Receives Eighth ANDA Approval from US FDA

10/31/2019

SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced it has received its eighth ANDA approval from the US Food and Drug Administration (FDA).
Lannett Enters Into Distribution Agreement For Generic Adderall®

3/11/2019

Lannett Company, Inc. announced that it has entered into an agreement with Elite Pharmaceuticals and SunGen Pharma to be the exclusive U.S. distributor of a generic version of Adderall®, an immediate-release mixed salt of a single entity Amphetamine tablet product, with strengths of 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg and 30 mg tablets.
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

8/14/2018

Elite Pharmaceuticals, Inc. today reported positive topline results from pivotal bioequivalence studies conducted for an undisclosed immediate-release antibiotic generic product being co-developed with SunGen Pharma.
Elite Pharma and SunGen Pharma File ANDA

2/9/2018

Under the terms of the Agreement, the product will be owned jointly by Elite and SunGen.
Elite Pharmaceuticals and SunGen Pharma File ANDA

2/8/2018

Under the terms of the Agreement, the product will be owned jointly by Elite and SunGen.
Athenex Division And SunGen Pharmaceuticals Announce Terbutaline Sulfate Injection Product Launch

8/31/2017
Elite Pharma Announces Co-Development Of Four Additional Products With SunGen Pharmaceuticals

7/28/2017
Elite Pharma Announces New Development And License Agreement With SunGen Pharmaceuticals

7/12/2017
Athenex And SunGen Pharmaceuticals Enter Into U.S. Joint Venture Agreement For A Portfolio Of 7 Approved Pharmaceutical Products

9/27/2016